Fiducial marker

Fiducient Advisors Names Sabrina Bailey as Its Next CEO

Retrieved on: 
Tuesday, July 18, 2023

CHICAGO, July 18, 2023 /PRNewswire-PRWeb/ -- Fiducient Advisors, an NFP company, today introduced Sabrina Bailey as the firm's next CEO. Bailey most recently served as London Stock Exchange Group plc's (LSEG) global head of Investment and Wealth Solutions. She succeeds Bob DiMeo, the firm's founder, who will become chairman and remain actively engaged in the business. Bailey will join Fiducient Advisors on July 31.

Key Points: 
  • CHICAGO, July 18, 2023 /PRNewswire-PRWeb/ -- Fiducient Advisors , an NFP company, today introduced Sabrina Bailey as the firm's next CEO.
  • Bailey will join Fiducient Advisors on July 31.
  • "I am delighted to welcome Sabrina as our new CEO and am confident she is poised to lead Fiducient Advisors on a continued path of success and growth," said DiMeo.
  • In January, then-current CEO, DiMeo, announced Fiducient Advisors' plan to initiate a nationwide search for the firm's next chief executive officer.

CIVCO Radiotherapy and Qfix Showcase as One Company at AAPM 2023

Retrieved on: 
Monday, July 17, 2023

CORALVILLE, Iowa, July 17, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual American Association of Physicists in Medicine (AAPM) 65th Annual Meeting in Houston, Texas, July 23-27, 2023.

Key Points: 
  • CORALVILLE, Iowa, July 17, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual American Association of Physicists in Medicine (AAPM) 65th Annual Meeting in Houston, Texas, July 23-27, 2023.
  • The company encourages attendees to visit booth #1411 to experience many of these solutions firsthand.
  • SBRT bridges, belts, and additional customization options are also available with the Alta™ Multipurpose Device (including Patient Transfer).
  • The Encompass™ and Solstice™ SRS Immobilization Systems are highly advanced, non-invasive solutions designed for precisely targeted brain, head, and neck treatments.

Government of Canada celebrates the launch of the $755 million Social Finance Fund in Quebec with Fonds de finance sociale - CAP Finance

Retrieved on: 
Monday, June 12, 2023

The Social Finance Fund is a foundational element of the Social Innovation and Social Finance Strategy, along with the Investment Readiness Program and the Social Innovation Advisory Council.

Key Points: 
  • The Social Finance Fund is a foundational element of the Social Innovation and Social Finance Strategy, along with the Investment Readiness Program and the Social Innovation Advisory Council.
  • Fonds de finance sociale – CAP Finance was announced as one of three fund managers for the Social Finance Fund on May 29, 2023 and will invest specifically in Quebec's unique social finance ecosystem to expand the social finance market in the province, including by increasing access to social finance for equity-deserving groups and for non-profit social purpose organizations.
  • I look forward to seeing the positive impacts the Social Finance Fund will have for Quebec and its diverse social finance ecosystem."
  • The remaining $705 million of the Social Finance Fund will be deployed by the fund managers into the social finance ecosystem.

Flow Cytometry Market To Reach A Revised Size of USD 8.4 Billion By 2028, Growing At A CAGR of 8.7% | Valuates Reports

Retrieved on: 
Wednesday, October 12, 2022

- Global Flow Cytometry Reagents Market Insights, Forecast to 2028

Key Points: 
  • - Global Flow Cytometry Reagents Market Insights, Forecast to 2028
    - The global digital polymerase chain reaction market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
  • - The global Hip Replacement market size is projected to reach USD 2688.1 million by 2028, from USD 2257.7 million in 2021, at a CAGR of 2.5% during 2022-2028.
  • - The global Orthopedic Devices market size is projected to reach USD 43250 million by 2027, from USD 34190 million in 2020, at a CAGR of 3.0% during 2021-2027.
  • - The global Biometrics market size is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.

ZOZO LAUNCHES ZOZOFIT 3D BODY MEASUREMENT SYSTEM TO REVOLUTIONIZE FIT TECHNOLOGY IN FITNESS AND BODY TRANSFORMATION

Retrieved on: 
Tuesday, August 23, 2022

The measurement system will retail for an introductory price of $98, which includes the ZOZOSUIT, ZOZOFIT app and unlimited scanning.

Key Points: 
  • The measurement system will retail for an introductory price of $98, which includes the ZOZOSUIT, ZOZOFIT app and unlimited scanning.
  • Launching today, ZOZOFIT along with its specially designed suit, is exclusively available in the United States on ZOZOFIT.com.
  • Accurately tracking body transformation over time can be challenging, especially when relying on tape measures (ripe for human error) or scales (weight being an inaccurate representation of body transformation).
  • ZOZO has also developed technology devices for body measurement, such as the ZOZOSUIT, ZOZOMAT, and ZOZOGLASS.

Fiducial Markers Market Will Reach USD 131.4 Million By 2028 With A CAGR of 3.9% - Valuates Reports

Retrieved on: 
Thursday, March 31, 2022

The global fiducial markers market is expected to grow as cancer prevalence rises around the world.

Key Points: 
  • The global fiducial markers market is expected to grow as cancer prevalence rises around the world.
  • Fiducial markers market growth is expected to be fueled by factors such as oncologists' increased adoption of radiotherapy treatment and devices.
  • Based on the product, the metal-based markers segment is expected to be the most lucrative segment in the fiducial markers market.
  • Based on end-user, The hospital segment is expected to be the most lucrative segment in the fiducial markers market.

Fiducial Markers Market Will Reach USD 131.4 Million By 2028 With A CAGR of 3.9% - Valuates Reports

Retrieved on: 
Thursday, March 31, 2022

The global fiducial markers market is expected to grow as cancer prevalence rises around the world.

Key Points: 
  • The global fiducial markers market is expected to grow as cancer prevalence rises around the world.
  • Fiducial markers market growth is expected to be fueled by factors such as oncologists' increased adoption of radiotherapy treatment and devices.
  • Based on the product, the metal-based markers segment is expected to be the most lucrative segment in the fiducial markers market.
  • Based on end-user, The hospital segment is expected to be the most lucrative segment in the fiducial markers market.

Roper Technologies to Divest CIVCO Radiotherapy

Retrieved on: 
Friday, October 22, 2021

Roper will retain its CIVCO Medical Solutions business, which will continue to operate independently.

Key Points: 
  • Roper will retain its CIVCO Medical Solutions business, which will continue to operate independently.
  • Roper Technologies is a constituent of the S&P 500, Fortune 500, and the Russell 1000 indices.
  • Roper operates businesses that design and develop software (both license and software-as-a-service) and engineered products and solutions for a variety of niche end markets.
  • CIVCO Radiotherapy has over 35 years experience developing, manufacturing, and providing high-quality, innovative, patient-centric solutions in radiotherapy.

CIVCO Radiotherapy to Exhibit In-Person and Virtually at ESTRO 2021

Retrieved on: 
Monday, August 23, 2021

CORALVILLE, Iowa, Aug. 23, 2021 /PRNewswire/ --CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will return to in-person exhibition, August 27 -31 in Madrid, Spain at the ESTRO 2021 (European Society for Radiotherapy & Oncology) meeting, booth 210.

Key Points: 
  • CORALVILLE, Iowa, Aug. 23, 2021 /PRNewswire/ --CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will return to in-person exhibition, August 27 -31 in Madrid, Spain at the ESTRO 2021 (European Society for Radiotherapy & Oncology) meeting, booth 210.
  • "We are excited to be back live at ESTRO 2021 to have face to face conversations with our providers and to continue demonstrating solutions for improving patient care and outcomes," said Nat Geissel, President of CIVCO Radiotherapy.
  • CIVCO RT's current innovations and solutions focusing on improving patient comfort, wellness, and outcomes, before, during and after treatment will be available for demonstration.
  • CIVCO Radiotherapy has over 35 years' experience developing, manufacturing and providing high-quality, innovative, patient-centric solutions in radiotherapy.

Deepen AI Expands Autonomous Systems Calibration Tool to Cover Five New Sensor Modes

Retrieved on: 
Wednesday, August 18, 2021

SANTA CLARA, Calif., Aug. 18, 2021 /PRNewswire/ -- Deepen AI, a world leader in computer vision tools for autonomous systems, today announcedkey new additions to theircalibration tool - Deepen Calibrate.

Key Points: 
  • SANTA CLARA, Calif., Aug. 18, 2021 /PRNewswire/ -- Deepen AI, a world leader in computer vision tools for autonomous systems, today announcedkey new additions to theircalibration tool - Deepen Calibrate.
  • "Companies with safety-critical multi-sensor systems recalibrate their systems infrequently due to the complexity and lack of expert individuals that can perform complex calibrations.
  • "- Cheuksan Wang, Co-Founder & CTO, Deepen AI
    Deepen Calibrate makes the critical task of sensor calibration simple and quick.
  • Key features of Deepen Calibrate include:
    Deepen Calibrate extends the company's suite of data lifecycle tools, including Deepen Annotate and Deepen Validate.